Pharmerica Revenue, Profits - PMC Annual Income Statement

Add to My Stocks
$29.25 $0.05 (0.17%) PMC stock closing price Dec 07, 2017 (Closing)

Fundamental analysis of PMC stock involves analyzing its financial statements, apart from checking the Pharmerica stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement for PMC which shows a YOY revenue growth of 3.09% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses as shown in the Pharmerica profit and loss statement for 2016 total to $287.6M. This line item shows that the operating expenses has increased compared with last year. Also check: Pharmerica assets and Pharmerica free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Pharmerica Revenues or Net Sales
2.09B2.03B1.89B1.76B1.83B2.08B1.85B1.84B1.95B
Cost Of Goods Sold (COGS)1.77B1.69B1.56B1.43B1.53B1.79B1.61B1.57B1.66B
Pharmerica Gross Profit
326M335.1M339.3M327.2M300.2M293.3M240.3M272.29M284.6M
Research & Development Expense---------
Selling General & Admin Expense253.9M252.7M288.8M256M239.1M235.3M195.2M192.8M255.6M
Income Before Depreciation Depletion Amortization72.1M82.39M50.5M71.2M61.09M58M45.1M79.49M29M
Depreciation Depletion Amortization33.7M28.6M20.1M15.4M12.3M11M9.3M9M6.5M
Non Operating Income---4.3M------
Interest Expense9.5M6.6M9.9M10.6M10M8.8M3.6M9.4M14.2M
Pharmerica Pretax Income
28.9M47.2M16.2M45.2M38.8M38.2M32.2M61.1M8.3M
Provision for Income Taxes7.3M12.1M9.4M26.3M15.9M14.8M13M18.9M3.3M
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations21.6M35.1M6.8M18.9M22.9M23.4M19.2M42.2M5M
Extraordinary Items & Discontinued Operations---------
Pharmerica Profit/ Loss (Net Income)
21.6M35.1M6.8M18.9M22.9M23.4M19.2M42.2M5M
Average Shares used to compute Diluted EPS31.16M30.77M30.65M30.08M29.9M29.47M30.13M30.4M30.19M
Average Shares used to compute Basic EPS30.7M30.36M29.98M29.6M29.47M29.34M30.01M30.27M30.1M
Income Before Nonrecurring Items60.55M47.1M46.03M49.58M37.85M35.43M27.9M39.48M28.73M
Income from Nonrecurring Items-38.95M-12M-39.23M-30.68M-14.95M-12.03M-8.7M2.72M-23.73M
Pharmerica Earnings Per Share Basic Net
0.701.160.230.640.780.800.641.390.17
Pharmerica Earnings Per Share Diluted Net
-1.14M-----1.39M-
EPS Diluted Before Nonrecurring Items1.941.531.501.651.271.200.931.300.95
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Pharmerica stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that PMC stock has a topline or revenue of $2.09B for 2016 as per this Pharmerica revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $21.6M for Pharmerica for 2016. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the PMC income statement, one can check the Pharmerica historical stock prices to check how the price has moved with time.

Pharmerica Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
47.95
PS Ratio (price sales ratio)
0.4
Operating Margin
2
Net Profit Margin
0.8
Dividend Yield
0%